![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 31/575 | (2006.01) |
A61K 31/56 | (2006.01) | ||
A61P 43/00 | (2006.01) | ||
A61P 1/16 | (2006.01) | ||
A61K 31/568 | (2006.01) | ||
A61K 35/12 | (2015.01) | ||
A61P 13/12 | (2006.01) |
(11) | Number of the document | 3086793 |
(13) | Kind of document | T |
(96) | European patent application number | 14874617.5 |
Date of filing the European patent application | 2014-12-23 | |
(97) | Date of publication of the European application | 2016-11-02 |
(45) | Date of publication and mention of the grant of the patent | 2022-05-11 |
(46) | Date of publication of the claims translation | 2022-08-25 |
(86) | Number | PCT/US2014/072128 |
Date | 2014-12-23 |
(87) | Number | WO 2015/100312 |
Date | 2015-07-02 |
(30) | Number | Date | Country code |
201361920617 P | 2013-12-24 | US |
(72) |
REN, Shunlin , US
THEEUWES, Felix , US
BROWN, James E. , US
LIN, WeiQi , US
|
(73) |
Virginia Commonwealth University ,
800 East Leigh Street
Suite 3000, Richmond, VA 23298,
US
The United States Government as Represented by the Department of Veterans Affairs , 810 Vermont Avenue, N.W., Washington, DC 20420, US Durect Corporation , 10260 Bubb Road, Cupertino, CA 95014, US |
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Deguonimi įsodrintų cholesterolio sulfatų (OCS) naudojimas inkstų disfunkcijai gydyti |
USE OF OXYGENATED CHOLESTEROL SULFATES (OCS) FOR THE TREATMENT OF KIDNEY DYSFUNCTION |
Payment date | Validity (years) | Amount | |
2023-12-04 | 10 | 231.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2024-12-23 |